Obesity Author: George A. Bray, MD
Editorial changes - 2009-11-06
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Quality Measures Quality Measures
Frequently Asked Questions
Prevention
Can obesity be prevented?
What strategies help prevent weight gain?
How do we evaluate the degree of overweight?
Screening
Why is BMI preferred over weight tables?
Can women have central fat distribution like men?
What diseases does obesity cause?
Diagnosis
Does obesity run in families?
What are the characteristics of the metabolic syndrome?
What are the major causes of obesity?
Consultation for Diagnosis
How important are genetic causes of obesity?
How common are endocrine causes of obesity?
What are the criteria for surgical treatment of obesity?
Hospitalization
How often is hospitalization indicated for obesity?
What are the problems associated with surgery for obesity?
Which operation produces the best weight loss in obese patients?
Non-drug Therapy
How effective is lifestyle treatment to losing weight?
How effective a strategy is exercise for losing weight?
How much weight will patients who are treated surgically lose?
Drug Therapy
What are the FDA-approved drugs to treat obesity?
Will sibutramine produce more weight loss than orlistat?
Do we have large controlled trials with herbal medications for weight loss?
Patient Education
How much weight loss can patients expect?
Do all drugs produce plateaus?
How much weight loss will behavioral treatment produce?
Consultation for Management
Who should administer behavioral therapy to obese patients?
What is the preferred surgical setting for bariatric surgery?
Who should administer the exercise program?
Follow-up
Does follow-up with patients help?
How often is it advisable to see patients?
What medications can be used for sleep apnea?
| Patient Information
George A. Bray, MD, is a speaker for Eli Lilly, Amylin Corp., and Merck & Co., received grants from Merck & Co., and Takeda Pharmaceuticals; and has consulted for Sanofi-Aventis, Merck, and Amylin.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.